Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

ulcers, infections, feeling weak or tired, cough and diarrhea. Common side effects of Afinitor in patients with SEGA include mouth ulcers, infections of the respiratory tract, sinuses and ears and fever.

Please see full Prescribing Information for Afinitor.

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "is being presented," "may," "can," "will," "potential," "ongoing," or similar expressions, or by express or implied discussions regarding potential new indications or labeling for everolimus or regarding potential future revenues from everolimus. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with everolimus to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that everolimus will be submitted or approved for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that everolimus will achieve any particular levels of revenue in the future. In particular, management's expectations regarding everolimus could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; government, industry and general public pricing pressures; competition in general; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and facto
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014  Lockton Dunning Benefits, the ... Companies, announced the addition of Vice President ... Lockton Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... industry experience to the position.  Most recently, she ... at Diplomat Specialty Pharmacy, where she has held ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014  Endo ... ENDP ) (TSX: ENL), and BioDelivery Sciences ... that they have submitted a New Drug Application (NDA) ... and Drug Administration (FDA).  Buprenorphine HCl Buccal Film is ... to require daily, around-the-clock, long-term opioid treatment and for ...
(Date:12/22/2014)... ALISO VIEJO, Calif. , Dec. 22, 2014 /PRNewswire/ ... moved into expanded corporate offices in Aliso ... President, announced that due to the tremendous growth and ... critically needed. Sales of patented SnoreRx, the anti snore ... administrative offices. He said, "We are now in ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... PARIS, September 13, 2010 ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... 11 The Mobile Dog Heart Health Tour is ... of free heart health examinations in San Antonio,s McAllister ... September 17, certified veterinary cardiologists will be performing on ... well as educating owners about canine heart disease. ...
Cached Medicine Technology:Biosystems International Merges With Microbiochips 2Biosystems International Merges With Microbiochips 3Biosystems International Merges With Microbiochips 4Biosystems International Merges With Microbiochips 5Biosystems International Merges With Microbiochips 6Biosystems International Merges With Microbiochips 7Free Dog Heart Checks at McAllister Park 2Free Dog Heart Checks at McAllister Park 3
(Date:12/24/2014)... 24, 2014 Attorneys handling talcum powder ... update to their website, the Talcum Powder Ovarian ... talcum powder class action lawsuits and ovarian cancer claims. ... ovarian cancer updates at their website, which serves as ... ovarian cancer claims are not the same as class ...
(Date:12/24/2014)... Final Cut Pro X plugin ... Film Studios. , “The ProDenoise plugin that allows users to ... said Christina Austin, CEO of Pixel Film Studios. “ProDenoise is ... X editors toolbox.” , Final Cut Pro X users can ... footage with ProDenoise from Pixel Film Studios. ProDenoise can quickly ...
(Date:12/24/2014)... 2014 In June 2014, 15 injured ... bicycles, hand cycles and recumbent bicycles nearly 800 miles ... CanAm Veterans’ Challenge . “Capital to Capital,” the ... about this inspiring ride, is now available through multiple ... color photographs taken during the two-week ride, the 92 ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 ... vaccine that U.S. officials are preparing to test in West ... vaccine produced a safe and potent immune response in Africans. ... more than 100 Ugandans in 2009 and 2010, prompted the ... protect a person against infection by Ebola, said study author ...
(Date:12/24/2014)... TUESDAY, Dec. 23, 2014 (HealthDay News) -- Longer and colder ... newborns who have brain damage from a lack of oxygen, ... disability in newborns with this condition -- called hypoxic ischemic ... to 33.5 degrees Celsius (92.3 Fahrenheit) for 72 hours, experts ... protects the brains of animals, so this study examined if ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 4Health News:Pixel Film Studios released the ProDenoise plugin for Final Cut Pro X today. 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 3Health News:Early Study Offers Hope for an Ebola Vaccine 2Health News:Early Study Offers Hope for an Ebola Vaccine 3Health News:Early Study Offers Hope for an Ebola Vaccine 4Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2
... New Ulm Project, which is merging environmental, peer leadership ... with the assistance of a healthcare system, worksites and ... shown a 24 percent reduction in the number of ... the previous five-quarter period of evaluation., This study will ...
... colleagues paired laboratory and epidemiologic data to find that men ... risk for prostate cancer. The scientists say further research ... or new ones that work the same way, to treat ... been used for centuries in folk medicine and for decades ...
... By Maureen Salamon HealthDay Reporter , FRIDAY, ... you unequivocally in minutes whether a baby is on the ... But, at-home genetic tests -- which may offer tantalizing ... infancy, and genetic counselors are concerned that the results may ...
... April 2011: Highly exciting new data presented today ... (PegIFN-lambda) shows superior virological response in HCV patients ... compared to Pegylated Interferon-alpha (PegIFN-alpha-2a), the current standard ... results are so important because they show PegIFN-lambda ...
... , FRIDAY, April 1 (HealthDay News) -- It,s important to ... activities, says Dr. Steven Greer, of the MCGHealth Sports Medicine ... parents and children. All children should undergo a physical ... inactive for an extended period of time, they should begin ...
... Researchers at the University of Pennsylvania School of ... acetylation has a previously unrecognized association with one of ... disorders. The findings were published in the latest issue ... one of the primary disease proteins associated with a ...
Cached Medicine News:Health News:Regional prevention project involving 10,000 adults cuts heart attacks by 25 percent 2Health News:Regional prevention project involving 10,000 adults cuts heart attacks by 25 percent 3Health News:Heart drug cuts prostate cancer risk; holds potential for therapeutic use 2Health News:Heart drug cuts prostate cancer risk; holds potential for therapeutic use 3Health News:Do At-Home Genetic Tests Tell Too Much and Explain Too Little? 2Health News:Do At-Home Genetic Tests Tell Too Much and Explain Too Little? 3Health News:PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a 2Health News:Tips for Keeping Young Athletes Safe 2Health News:Penn study suggests another avenue for detecting Alzheimer's disease 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: